Related references
Note: Only part of the references are listed.Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas
Tatiany L. Silveira et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2020)
COX-2 as a potential biomarker and therapeutic target in melanoma
Diana Valentina Tudor et al.
CANCER BIOLOGY & MEDICINE (2020)
The selective cyclooxygenase-2 inhibitor mavacoxib (Trocoxil) exerts anti-tumour effects in vitro independent of cyclooxygenase-2 expression levels
Emma A. Hurst et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2019)
Immunohistochemical expression of cyclooxygenase-2 (COX-2) in oral nevi and melanoma
Juliana de Souza do Nascimento et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2016)
Cross-species models of human melanoma
Louise van der Weyden et al.
JOURNAL OF PATHOLOGY (2016)
Mitotic Count and the Field of View Area: Time to Standardize
D. J. Meuten et al.
VETERINARY PATHOLOGY (2016)
Investigating associations of cyclooxygenase-2 expression with angiogenesis, proliferation, macrophage and T-lymphocyte infiltration in canine melanocytic tumours
Hugo Gregorio et al.
MELANOMA RESEARCH (2016)
Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy
Lisa Y. Pang et al.
STEM CELLS INTERNATIONAL (2016)
Cyclooxygenase inhibitors: From pharmacology to clinical read-outs
Paola Patrignani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Characterization of Microsomal Prostaglandin E Synthase 1 Inhibitors
Marina Korotkova et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
The long-acting COX-2 inhibitor mavacoxib (Trocoxil¿) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells
Lisa Y Pang et al.
BMC Veterinary Research (2014)
Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness
Claudia Bocca et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma
Ryoichi Fujii et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Global Gene Expression Analysis of Canine Osteosarcoma Stem Cells Reveals a Novel Role for COX-2 in Tumour Initiation
Lisa Y. Pang et al.
PLOS ONE (2014)
Antitumor effects of celecoxib in COX-2 expressing and non-expressing canine melanoma cell lines
Kyoung-won Seo et al.
RESEARCH IN VETERINARY SCIENCE (2014)
Abnormal COX2 Protein Expression May Be Correlated with Poor Prognosis in Oral Cancer: A Meta-Analysis
Zhi-Ming Wang et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma
Anna A. Brozyna et al.
HUMAN PATHOLOGY (2013)
Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype
A. Cervantes-Arias et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2013)
Interaction between cyclooxygenase-2, Snail, and E-cadherin in gastric cancer cells
Xiao-Jun Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy
Muzammal Hussain et al.
PHARMACOLOGICAL RESEARCH (2012)
Rising Incidence of Mucosal Melanoma of the Head and Neck in the United States
David M. Marcus et al.
JOURNAL OF SKIN CANCER (2012)
Immunohistochemical Diagnosis of Canine Oral Amelanotic Melanocytic Neoplasms
R. C. Smedley et al.
VETERINARY PATHOLOGY (2011)
Cyclooxygenase-2 Expression Is Related With Localization, Proliferation, and Overall Survival in Canine Melanocytic Neoplasms
C. M. Martinez et al.
VETERINARY PATHOLOGY (2011)
Prognostic Markers for Canine Melanocytic Neoplasms: A Comparative Review of the Literature and Goals for Future Investigation
R. C. Smedley et al.
VETERINARY PATHOLOGY (2011)
COX-1 and COX-2 Expression in Canine Cutaneous, Oral and Ocular Melanocytic Tumours
I. Pires et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2010)
Heterogeneous Phenotype of Human Melanoma Cells with In Vitro and In Vivo Features of Tumor-Initiating Cells
Michela Perego et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Aspirin Use, Colorectal Cancer Survival, and Loss to Follow-up Reply
Andrew T. Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
COX-2 expression in malignant melanoma: a novel prognostic marker?
Maria R. Becker et al.
MELANOMA RESEARCH (2009)
Cox-2 Expression in Canine Mammary Carcinomas: Correlation with Angiogenesis and Overall Survival
G. E. Lavalle et al.
VETERINARY PATHOLOGY (2009)
Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-β through a PGE2-dependent mechanisms
Jason R. Neil et al.
CARCINOGENESIS (2008)
Identification of cells initiating human melanomas
Tobias Schatton et al.
NATURE (2008)
A reduction of cyclooxygenase 2 gene dosage counters the ovarian morphological aging and tumor phenotype in Wv mice
Wan-Lin Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential
Elena Monzani et al.
EUROPEAN JOURNAL OF CANCER (2007)
Cutaneous malignant melanoma
DL Cummins et al.
MAYO CLINIC PROCEEDINGS (2006)
A tumorigenic subpopulation with stem cell properties in melanomas
D Fang et al.
CANCER RESEARCH (2005)
Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer
SI Mohammed et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines
Y Nakanishi et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
